AGEN

SEC source: 0001288123-17-000015 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,220

Underlying: Common Stock · 21,220 shares

Expires 2018-03-31

F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

SEC source: 0001288123-17-000013 · primary_doc.xml · derivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · President R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-03-31

F1 · derivative.exercise_date: Options vest one-third on the one-year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date.

SEC source: 0001288123-17-000012 · primary_doc.xml · derivative · entry 1

Baysal Ozer · CIK 0001579446 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2027-03-31

F1 · derivative.exercise_date: Options vest one-third on the one-year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date.

SEC source: 0001288123-17-000011 · primary_doc.xml · derivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,500

Underlying: Common Stock · 72,500 shares

Expires 2027-03-31

F1 · derivative.exercise_date: Options vest one-third on the one-year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date.

SEC source: 0001288123-17-000010 · primary_doc.xml · derivative · entry 1

Valentine Karen · CIK 0001437152 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,500

Underlying: Common Stock · 162,500 shares

Expires 2027-03-31

F1 · derivative.exercise_date: Options vest one-third on the one-year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date.

SEC source: 0001288123-17-000009 · primary_doc.xml · derivative · entry 1

Cuillerot Jean-Marie · CIK 0001696108 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,500

Underlying: Common Stock · 232,500 shares

Expires 2027-03-31

F1 · derivative.exercise_date: Options vest one-third on the one year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date.

SEC source: 0001288123-17-000008 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,166

Underlying: Common Stock · 4,166 shares

Expires 2027-03-16

F1 · derivative.exercise_date: 100% of options vest on one-year anniversary of the grant date.

SEC source: 0001288123-17-000007 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2027-03-08

F1 · derivative.exercise_date: 100% of options vest on one-year anniversary of the grant date.

SEC source: 0001104659-17-009341 · a4.xml · nonDerivative · entry 1

INCYTE CORP · CIK 0000879169 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,763,968

SEC source: 0001288123-17-000006 · primary_doc.xml · derivative · entry 1

Cuillerot Jean-Marie · CIK 0001696108 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-01-26

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests in three equal annual installments beginning on the one-year anniversary of the grant date.

SEC source: 0001288123-17-000004 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,166

Underlying: Common Stock · 4,166 shares

Expires 2027-01-25

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan, and vests in one installment on the one-year anniversary of the grant date.

SEC source: 0001288123-17-000002 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,280.518

Underlying: Common Stock · 1,280.518 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-17-000003 · primary_doc.xml · nonDerivative · entry 1

Baysal Ozer · CIK 0001579446 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,883

F1 · kind: Represents the settlement of restricted stock awarded on January 2, 2013.

SEC source: 0001288123-17-000001 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,998.287

Underlying: Common Stock · 2,998.287 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-16-000096 · primary_doc.xml · nonDerivative · entry 2

ARMEN GARO H · CIK 0000935679 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,318,477

F1 · kind: Represents shares donated to a charitable organization.

SEC source: 0001288123-16-000096 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,470,882

F1 · kind: Represents shares donated to a charitable organization.

SEC source: 0001288123-16-000095 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,096.726

Underlying: Common Stock · 1,096.726 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-16-000094 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,567.944

Underlying: Common Shares · 2,567.944 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-16-029397 · doc4.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,037

Underlying: Common Stock · 53,037 shares

Expires 2026-09-16

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Inventive Plan, and vests in one installment on the one-year anniversary of the grant date.

SEC source: 0000899243-16-029413 · doc4.xml · derivative · entry 1

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,711

Underlying: Common Stock · 13,711 shares

Expires 2026-09-16

F1 · shares: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Inventive Plan, and vests in one installment on the one-year anniversary of the grant date.

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Inventive Plan, and vests in one installment on the one-year anniversary of the grant date.

SEC source: 0000899243-16-029402 · doc4.xml · derivative · entry 1

Valentine Karen · CIK 0001437152 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,083

Underlying: Common Stock · 2,083 shares

Expires 2026-09-16

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Inventive Plan, and vests in one installment on the one-year anniversary of the grant date.

SEC source: 0000899243-16-029400 · doc4.xml · derivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · VP Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,551

Underlying: Common Stock · 7,551 shares

Expires 2026-09-16

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Inventive Plan, and vests in one installment on the one-year anniversary of the grant date.

SEC source: 0001288123-16-000093 · primary_doc.xml · nonDerivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000